|
May 27
|
Junshi Biosciences Announces Ongericimab’s sNDA Approval in China
|
|
May 8
|
BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate
|
|
Apr 25
|
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
|